Cargando…
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review
Background: Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of inhibitor eradication with immunosuppressive therapy (IST) and prompt control of bleeding obtained with bypassing agents or recombinant...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380857/ https://www.ncbi.nlm.nih.gov/pubmed/37510704 http://dx.doi.org/10.3390/jcm12144590 |
_version_ | 1785080298719936512 |
---|---|
author | Sella, Carola Bardetta, Marco Valeri, Federica Dainese, Cristina Valpreda, Alessandra Massaia, Massimo Grimaldi, Daniele Porreca, Annamaria Bruno, Benedetto Borchiellini, Alessandra |
author_facet | Sella, Carola Bardetta, Marco Valeri, Federica Dainese, Cristina Valpreda, Alessandra Massaia, Massimo Grimaldi, Daniele Porreca, Annamaria Bruno, Benedetto Borchiellini, Alessandra |
author_sort | Sella, Carola |
collection | PubMed |
description | Background: Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of inhibitor eradication with immunosuppressive therapy (IST) and prompt control of bleeding obtained with bypassing agents or recombinant porcine FVIII (rpFVIII). The latter has recently been licensed for management of acute bleeding in AHA. Unlike treatment with bypassing agents, rpFVIII can be monitored to provide a successful hemostatic effect and avoid overtreatment. Correlation between rpFVIII inhibitor titers and efficacy of rpFVIII treatment remains a matter of debate. Methods: We report three cases of AHA in which rpFVIII was successfully used with an unconventional schedule despite the presence of medium–high titers of the rpFVIII. The modified Nijmegen–Bethesda inhibitor assay (NBA) was used to dose porcine FVIII inhibitors. Result: The presence of rpFVIII inhibitors prior to the exposition to susoctocog-alfa, that may suggest a cross-reactivity with human FVIII inhibitors, did not affect hemostasis. Conclusion: In our experience, rpFVIII demonstrates safety and efficacy in the presence of rpFVIII inhibitors and using an unconventional schedule in both the perioperative and outpatient settings. Laboratory measurement of inhibitors against rpFVIII during treatment is described for the first time. |
format | Online Article Text |
id | pubmed-10380857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103808572023-07-29 Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review Sella, Carola Bardetta, Marco Valeri, Federica Dainese, Cristina Valpreda, Alessandra Massaia, Massimo Grimaldi, Daniele Porreca, Annamaria Bruno, Benedetto Borchiellini, Alessandra J Clin Med Case Report Background: Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of inhibitor eradication with immunosuppressive therapy (IST) and prompt control of bleeding obtained with bypassing agents or recombinant porcine FVIII (rpFVIII). The latter has recently been licensed for management of acute bleeding in AHA. Unlike treatment with bypassing agents, rpFVIII can be monitored to provide a successful hemostatic effect and avoid overtreatment. Correlation between rpFVIII inhibitor titers and efficacy of rpFVIII treatment remains a matter of debate. Methods: We report three cases of AHA in which rpFVIII was successfully used with an unconventional schedule despite the presence of medium–high titers of the rpFVIII. The modified Nijmegen–Bethesda inhibitor assay (NBA) was used to dose porcine FVIII inhibitors. Result: The presence of rpFVIII inhibitors prior to the exposition to susoctocog-alfa, that may suggest a cross-reactivity with human FVIII inhibitors, did not affect hemostasis. Conclusion: In our experience, rpFVIII demonstrates safety and efficacy in the presence of rpFVIII inhibitors and using an unconventional schedule in both the perioperative and outpatient settings. Laboratory measurement of inhibitors against rpFVIII during treatment is described for the first time. MDPI 2023-07-10 /pmc/articles/PMC10380857/ /pubmed/37510704 http://dx.doi.org/10.3390/jcm12144590 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Sella, Carola Bardetta, Marco Valeri, Federica Dainese, Cristina Valpreda, Alessandra Massaia, Massimo Grimaldi, Daniele Porreca, Annamaria Bruno, Benedetto Borchiellini, Alessandra Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title | Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title_full | Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title_fullStr | Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title_full_unstemmed | Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title_short | Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review |
title_sort | surgery and prophylaxis with susoctocog-alfa in acquired hemophilia: case series and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380857/ https://www.ncbi.nlm.nih.gov/pubmed/37510704 http://dx.doi.org/10.3390/jcm12144590 |
work_keys_str_mv | AT sellacarola surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT bardettamarco surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT valerifederica surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT dainesecristina surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT valpredaalessandra surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT massaiamassimo surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT grimaldidaniele surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT porrecaannamaria surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT brunobenedetto surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview AT borchiellinialessandra surgeryandprophylaxiswithsusoctocogalfainacquiredhemophiliacaseseriesandliteraturereview |